MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Cancer Immunotherapy and Biomarkers
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,980 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,980 works in the cohort · of 4,299,418page 5 of 60

Labels cover 12 of 2,980 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,980 of 2,980 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Cancer immunotherapy and the value of cure
Joseph C. Del Paggio
2018· review· en· Nature Reviews Clinical Oncology· Medicine
distilled prediction:candidate · research_integrityconsensus · research_integrity
188
citations
affno abstractunlabeled
Safety, Efficacy, and Patient-Reported Health-Related Quality of Life and Symptom Burden with Nivolumab in Patients with Advanced Non–Small Cell Lung Cancer, Including Patients Aged 70 Years or Older or with Poor Performance Status (CheckMate 153)
David R. Spigel, Michael McCleod, Robert M. Jotte, Lawrence H. Einhorn, Leora Horn, David Waterhouse +15 more
2019· article· en· Journal of Thoracic Oncology· Medicine
distilled prediction:candidate · noneconsensus · none
187
citations
afffundunlabeled
LAG3’s Enigmatic Mechanism of Action
Colin Graydon, Shifa Mohideen, Keith R. Fowke
2021· review· en· Frontiers in Immunology· Medicine
distilled prediction:candidate · noneconsensus · none
181
citations
affno abstractunlabeled
First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study
Siow Ming Lee, Christian Schulz, Kumar Prabhash, Dariusz M. Kowalski, Aleksandra Szczęsna, Baohui Han +20 more
2023· article· en· The Lancet· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
158
citations
affunlabeled
Is cancer biology different in older patients?
Yannick Van Herck, Annelies Feyaerts, Shabbir M.H. Alibhai, Demetris Papamichael, Lore Decoster, Yentl Lambrechts +7 more
2021· review· en· The Lancet Healthy Longevity· Medicine
distilled prediction:candidate · noneconsensus · none
158
citations
affno abstractunlabeled
PD-L1 Testing in Cancer
Aaron R. Hansen, Lillian L. Siu
2015· article· en· JAMA Oncology· Medicine
distilled prediction:candidate · noneconsensus · none
156
citations
affunlabeled
Defining the critical hurdles in cancer immunotherapy
Bernard A. Fox, Dolores J. Schendel, Lisa H. Butterfield, Steinar Aamdal, James P. Allison, Paolo A. Ascierto +99 more
2011· editorial· en· Journal of Translational Medicine· Medicine
distilled prediction:candidate · insufficient_payloadconsensus · none
155
citations

How this was built: Screen · Findings · About